Paper20134372
Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation.
Gen R and 2 others. South Med J, 2010. Cited by 94 papers, by iCite.
Cite this record
ConductScience Library. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. Papers, record 20134372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20134372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Helicobacter Infections | Major topic |
| Helicobacter pylori | Major topic |
| Inflammation | Major topic |
| Insulin Resistance | Major topic |
| Lipids | Major topic |
| 2-Pyridinylmethylsulfinylbenzimidazoles | |
| Adult | |
| Amoxicillin | |
| Anti-Bacterial Agents | |
| C-Reactive Protein | |
| Case-Control Studies | |
| Female | |
| Humans | |
| Male | |
| Metronidazole | |
| Pantoprazole | |
| Prospective Studies | |
| Proton Pump Inhibitors |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 20134368 | Considering global vaccination against Helicobacter pylori. | https://conductscience.org/library/papers/20134368 | PubMed |
| Comment in | 20818321 | Interventional studies to confirm association of Helicobacter pylori and insulin resistance: a winding road. | https://conductscience.org/library/papers/20818321 | PubMed |
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42924136 | Chronic systemic inflammation: A common pathway linking chronic diseases. | Caspian J Intern Med | 2026 | https://conductscience.org/library/papers/42924136 | PubMed |
| 42529751 | Outcomes of Helicobacter Pylori eradication on lipid profiles and cardiovascular disease risk: a systematic review, meta-analysis, and meta-regression. | Gastroenterol Hepatol Bed Bench | 2026 | https://conductscience.org/library/papers/42529751 | PubMed |
| 42009715 | Helicobacter pylori infection and liver function alterations in individuals undergoing gastric cancer screening: a cohort study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42009715 | PubMed |
| 41639964 | Association between Helicobacter pylori infection and insulin resistance: Data from the US and Chinese cohorts. | J Int Med Res | 2026 | https://conductscience.org/library/papers/41639964 | PubMed |
| 41179711 | Helicobacter pylori infection as a risk factor in the development of metabolic dysfunction-associated steatotic liver disease. | World J Hepatol | 2025 | https://conductscience.org/library/papers/41179711 | PubMed |
| 40893911 | Helicobacter pylori infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes. | Metabol Open | 2025 | https://conductscience.org/library/papers/40893911 | PubMed |
| 39857728 | Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies. | Biomedicines | 2025 | https://conductscience.org/library/papers/39857728 | PubMed |
| 38569609 | Type 2 Diabetes Mellitus and Helicobacter pylori Eradication in a Clinical Population. | South Med J | 2024 | https://conductscience.org/library/papers/38569609 | PubMed |
| 38500481 | Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients. | J Multidiscip Healthc | 2024 | https://conductscience.org/library/papers/38500481 | PubMed |
| 37779702 | Causality of anti-Helicobacter pylori IgG levels on myocardial infarction and potential pathogenesis: a Mendelian randomization study. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37779702 | PubMed |
| 36619724 | The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial. | Middle East J Dig Dis | 2022 | https://conductscience.org/library/papers/36619724 | PubMed |
| 36096730 | Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a Sub-Saharan setting. | BMC Infect Dis | 2022 | https://conductscience.org/library/papers/36096730 | PubMed |
| 36074383 | Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension. | Arq Bras Cardiol | 2022 | https://conductscience.org/library/papers/36074383 | PubMed |
| 35600431 | The association of Helicobacter Pylori infection with dyslipidaemia and other atherogenic factors in dyspeptic patients at St. Paul's Hospital Millennium Medical College. | Heliyon | 2022 | https://conductscience.org/library/papers/35600431 | PubMed |
| 34835476 | Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension. | Microorganisms | 2021 | https://conductscience.org/library/papers/34835476 | PubMed |
| 34683138 | Increased Glycated Hemoglobin but Decreased Cholesterol after a Loss of Helicobacter pylori Infection: A Community-Based Longitudinal Metabolic Parameters Follow-Up Study. | J Pers Med | 2021 | https://conductscience.org/library/papers/34683138 | PubMed |
| 34431440 | Helicobacter pylori increases the risk of carotid plaque formation: a clinical evidence. | Ann Med | 2021 | https://conductscience.org/library/papers/34431440 | PubMed |
| 34211711 | Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study. | SAGE Open Med | 2021 | https://conductscience.org/library/papers/34211711 | PubMed |
| 33935515 | Relationship Between Helicobacter pylori Infection and Arteriosclerosis. | Int J Gen Med | 2021 | https://conductscience.org/library/papers/33935515 | PubMed |
| 33668848 | The Effect of Helicobacter pylori Eradication on Lipid Levels: A Meta-Analysis. | J Clin Med | 2021 | https://conductscience.org/library/papers/33668848 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20134372
GET https://conductscience.org/api/papers/v1/20134372/cited_by?page=2